Events of American Cyclodextrin Consortium
Virtual Meeting Jun 25, 2026, 10:00 AM – 11:00 AM PDT Zoom: https://us02web.zoom.us/j/86748849340 Virtual meetings are held quarterly. The next
Events of American Cyclodextrin Consortium
Virtual Meeting Jun 25, 2026, 10:00 AM – 11:00 AM PDT Zoom: https://us02web.zoom.us/j/86748849340 Virtual meetings are held quarterly. The next
Ultrafast-dissolving ocular microneedle patch with voriconazole-cyclodextrin complex
Fungal keratitis (FK) is a leading cause of corneal blindness worldwide. Although voriconazole (VOR) is effective, its poor corneal permeability
Nano-Enabled Toxicity of Pharmaceutical Excipients
Nanotechnology has brought revolutionary advances in the pharmaceutical field. Among drug delivery systems, nanocarriers, which enhance the solubility, stability and
Cyclodextrins Across the Eye-Care Spectrum
When people talk about innovative eye-care products, the spotlight usually goes to ingredients like hyaluronic acid, panthenol, collagen, botanical extracts
Biphasic dissolving microneedles with cyclodextrin inclusion complexes for enhanced delivery of poorly soluble drugs
Dissolving microneedles (DMNs) have been widely investigated for transdermal drug delivery, yet their clinical translation and commercialization remain limited, primarily
CD-based supramolecular polymers based on host–guest interactions for cancer therapy
Cyclodextrin-based supramolecular polymers (SPCDs) have emerged as promising platforms for cancer therapy via the utilization of cyclodextrin (CD)-mediated host-guest interactions
PEG-β-Cyclodextrin polymer-based formulation to increase the antiangiogenic activity of rutin in vivo
Rutin (RTN) is a natural flavonoid with well-documented anti-angiogenic, antioxidant, anti-inflammatory, and anti-cancer properties. However, its therapeutic potential is limited
Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
Cyclarity Therapeutics, Inc., a clinical stage biopharmaceutical company engineering cyclodextrin molecules into simple, scalable, and affordable therapies that bind and
Methyl salicylate/methyl-β-cyclodextrin inclusion complex modulates plant defense against cold and heat stress
Methyl salicylate (MeSA), a known defense modulator, holds promise as a biostimulant; however, its volatility and poor aqueous solubility limit
CDs as Modulators of Regulated Cell Death: Implications for Immunometabolism and Therapeutic Innovation
This review critically examines how cyclodextrins modulate regulated cell death pathways and the implications for immunometabolism and therapeutic translation. Increasing